The China Securities Regulatory Commission has opened an investigation into Shenzhen Yahuilong Biotechnology Co., Ltd. after the company's Jan. 7, 2026 announcement that it had signed a strategic cooperation framework agreement was suspected of containing a misleading statement, and the regulator said it will handle the case in accordance with the law after completing a full investigation.
China Securities Regulatory Commission2026-02-06
China Securities Regulatory Commission opens investigation into Yahuilong over suspected misleading statement in strategic cooperation framework agreement announcement
The China Securities Regulatory Commission has opened an investigation into Shenzhen Yahuilong Biotechnology Co., Ltd. over a suspected misleading statement in the company's Jan. 7, 2026 announcement on signing a strategic cooperation framework agreement.